-
1 Comment
PYC Therapeutics Limited is currently in a long term downtrend where the price is trading 1.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
PYC Therapeutics Limited's total revenue rose by 99.5% to $58K since the same quarter in the previous year.
Its net income has dropped by 250.8% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 237.3% to $-3M since the same quarter in the previous year.
Based on the above factors, PYC Therapeutics Limited gets an overall score of 2/5.
Industry | Biotechnology |
---|---|
Sector | Healthcare |
ISIN | AU000000PYC7 |
CurrencyCode | AUD |
Exchange | AU |
Beta | 0.32 |
---|---|
Market Cap | 214M |
Dividend Yield | 0.0% |
Target Price | 0.2 |
PE Ratio | 0.0 |
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PYC.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024